Form 8-K - Current report:
SEC Accession No. 0001181431-09-018909
Filing Date
2009-04-03
Accepted
2009-04-03 11:19:12
Documents
3
Period of Report
2009-03-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 rrd239113.htm 8-K 14237
2 CONSULTING AGREEMENT BETWEEN THE COMPANY AND DR. WOLFE DATED APRIL 1, 2009. rrd239113_27969.htm EX-10.1 10259
3 SEPARATION AGREEMENT BETWEEN THE COMPANY AND DR. WOLFE DATED MARCH 31, 2009. rrd239113_27970.htm EX-10.2 12974
  Complete submission text file 0001181431-09-018909.txt   39254
Mailing Address 5110 CAMPUS DRIVE PLYMOUTH MEETING PA 19462
Business Address 5110 CAMPUS DR PLYMOUTH MEETING PA 19462 6109415231
GENAERA CORP (Filer) CIK: 0000880431 (see all company filings)

EIN.: 133445668 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19651 | Film No.: 09730600
SIC: 2836 Biological Products, (No Diagnostic Substances)